Show simple item record

dc.contributor.authorde Wit, Jelle
dc.contributor.authorEmmelot, Maarten E
dc.contributor.authorPoelen, Martien C M
dc.contributor.authorLanfermeijer, Josien
dc.contributor.authorHan, Wanda G H
dc.contributor.authorvan Els, Cécile A C M
dc.contributor.authorKaaijk, Patricia
dc.date.accessioned2019-02-18T11:42:35Z
dc.date.available2019-02-18T11:42:35Z
dc.date.issued2019-01-09
dc.identifier.issn1098-5514
dc.identifier.pmid30626672
dc.identifier.doi10.1128/JVI.01883-18
dc.identifier.urihttp://hdl.handle.net/10029/622781
dc.description.abstractMumps outbreaks among vaccinated young adults stress the need for a better understanding of the mumps virus (MuV)-induced immunity. Antibody responses to MuV are well-characterized, but studies on T cell responses are limited. We recently isolated a MuV-specific CD4en_US
dc.language.isoenen_US
dc.titleThe human CD4 T cell response against mumps virus targets a broadly recognized nucleoprotein epitope.en_US
dc.typeArticleen_US
dc.identifier.journalJ Virol 2019; 93(6):e01883-18en_US
dc.source.journaltitleJournal of virology


This item appears in the following Collection(s)

Show simple item record